Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2011-08-30
2011-08-30
Stoica, Elly-Gerald (Department: 1647)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C435S007210, C435S006120, C435S007100
Reexamination Certificate
active
08007769
ABSTRACT:
Methods are provided for the diagnosis and treatment of patients with increased risk of preeclampsia. The methods involve measuring levels of TGF-β3, receptors of cytokines of the TGβ family, or HIF-1α.
REFERENCES:
patent: 6376199 (2002-04-01), Caniggia et al.
patent: 6863880 (2005-03-01), Caniggia et al.
patent: 7445940 (2008-11-01), Caniggia et al.
patent: 2005/0136468 (2005-06-01), Caniggia et al.
patent: 2009/0098146 (2009-04-01), Caniggia et al.
patent: 2009/0246773 (2009-10-01), Caniggia et al.
patent: WO 98/40747 (1998-09-01), None
patent: WO 2007/104145 (2007-09-01), None
Aplin, “Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro”, Journal of Cell Science, vol. 99, No. 4, (Aug. 1991), pp. 681-692.
Bass, “Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process”, Developmental Biology, vol. 164, No. 2, (Aug. 1994), pp. 550-561.
Bischof, “Localization of α2, α5 and α6 integrin subunits in human endometrium, decidua and trophoblast”, European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 51, No. 3, (Oct. 29, 1993), pp. 217-226.
Bischof, “Gelatinase and oncofetal fibronectin secretion is dependent on integrin expression on human cytotrophoblasts”, Human Reproduction, vol. 10, No. 3, (Mar. 1995), pp. 734-742.
Caniggia, “Endoglin regulates trophoblast invasion in human placental villous tissue explants”, Biological Reproduction, vol. 52, No. 9 Supplement, (Jul. 1997), pp. 164.
Caniggia, “Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants”, Endocrinology, vol. 138, No. 11, (Nov. 1, 1997), pp. 4977-4988.
Caniggia, “Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies”, The Journal of Clinical Investigation, vol. 103, No. 12, (Jun. 1999), pp. 1641-1650.
Caniggia, “Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ(3)”, The Journal of Clinical Investigation, vol. 105, No. 5, (Mar. 2000), pp. 577-587.
Caniggia, “Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia”, Placenta, vol. 21, Supplemental A (Mar.-Apr. 2000), pp. S25-30.
Caniggia, “Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies—a review”, Placenta, vol. 23, Supplemental A, (Apr. 2002), pp. S47-57.
Cheifetz, “Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells”, The Journal of Biological Chemistry, vol. 267, No. 27, (Sep. 25, 1992), pp. 19027-19030.
Cross, “Implantation and the placenta: key pieces of the development puzzle”, Science, vol. 266, No. 5190, (Dec. 2, 1994), pp. 1508-1518.
Damsky, “Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo”,The Journal of Clinical Investigation, vol. 89, No. 1, (Jan. 1992), pp. 210-222.
Damsky, “Integrin switching regulates normal trophoblast invasion”, Development, vol. 120, No. 12, (Dec. 1994), pp. 3657-3666.
Engvall, “Binding of soluble form of fibroblast surface protein, fibronectin, to collagen”, International Journal of Cancer, vol. 20, No. 1, (Jul. 15, 1977) pp. 1-5.
Feinberg, “Transforming growth factor-β stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo”, The Journal of Clinical Endocrinology and Metabolism, vol. 78, No. 5, (May 1994), pp. 1241-1248.
Feinberg, “Is oncofetal fibronectin a trophoblast glue for human implantation?”, The American Journal of Pathology, vol. 138, No. 3, (Mar. 1991) pp. 537-543.
Fisher, “Adhesive and degradative properties of human placental cytotrophoblast cells in vitro”, The Journal of Cell Biology, vol. 109, No. 2, (Aug. 1989), pp. 891-902.
Genbacev, “Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia”, The Journal of Clinical Investigation, vol. 97, No. 2, (Jan. 15, 1996), pp. 540-550.
Genbacev, “Villous culture of first trimester human placenta-model to study extravillous trophoblast (EVT) differentiation”, Placenta, vol. 13, No. 5, (Sep.-Oct. 1992), pp. 439-461.
Gougos, “Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts”, International Immunology, vol. 4, No. 1, (Jan. 1992), pp. 83-92.
Gougos, “Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells”, The Journal of Biological Chemistry, vol. 265, No. 15, (May 25, 1990), pp. 8361-8364.
Graham, “Mechanisms of placental invasion of the uterus and their control”, Biochemistry and Cell Biology, vol. 70, No. 10, (Oct. 1, 1992), pp. 867-874.
Graham, “Molecular mechanisms controlling trophoblast invasion of the uterus”, Trophoblast Research, vol. 7, (1993), pp. 237-250.
Graham, “Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation”, Biological Reproduction, vol. 46, No. 4, (Apr. 1992), pp. 561-572.
Graham, “Mechanism of control of trophoblast invasion in situ”, Journal of Cellular Physiology, vol. 148, No. 2, (Aug. 1991), pp. 228-234.
Griffin, JF, Pregnancy-associated plasma protein levels at term in normal pregnancy, preeclampsia and essential hypertension, The Australian and New Zealand Journal of Obstetrics and Gynaecology, 23(1):11-14 (Feb. 1983).
Irving, “Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1”, Experimental Cell Research, vol. 217, No. 2, (Apr. 1995), pp. 419-427.
Lastres, “Endoglin modulates cellular responses to TGF-β1”, The Journal of Cell Biology, vol. 133, No. 5, (Jun. 1996), pp. 1109-1121.
Librach, “Interleukin-1β regulates human cytotrophoblast metalloproteinase activity and invasion in vitro”, The Journal of Biological Chemistry, vol. 269, No. 25, (Jun. 24, 1994), pp. 17125-17131.
Lebrin, “TGF-β receptor function in the endothelium”, Cardiovascular Research, vol. 65, No. 3, (Feb. 15, 2005), pp. 599-608.
Lysiak, “Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation”, Placenta, vol. 16, No. 3, (Apr. 1995), pp. 221-231.
Malcolm, “Uses of antisense nucleic acids—an introduction”, Biochemical Society Transactions, vol. 20, No. 4, (Nov. 1992), pp. 745-746.
Massague, “TGF β signaling in growth control, cancer, and heritable disorders”, Cell, vol. 103, No. 2, (Oct. 13, 2000), pp. 295-309.
Mitchell, “Subtypes of βglycan and of type I and type II transforming growth factor-β (TGF-β) receptors with different affinities for TGF-β1 and TGF-β2 are exhibited by human placental trophoblast cells”, Journal of Cellular Physiology, vol. 150, No. 2, (Feb. 1992), pp. 334-343.
Munson, “Transforming growth factor β in bovine placentas”, Biology of Reproduction, vol. 55, No. 4, (Oct. 1996), pp. 748-755.
Quackenbush, “Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies”, The Jo
Caniggia Isabella
Lye Stephen
Post Martin
Howson & Howson LLP
Mount Sinai Hospital
Stoica Elly-Gerald
LandOfFree
Method for diagnosing an increased risk of preeclampsia by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing an increased risk of preeclampsia by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing an increased risk of preeclampsia by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2766278